Roundup Class Action Settlement Reached Over Advertisement Claims

Bloomberg News reports that Bayer has reached an agreement settle a Roundup class action lawsuit, agreeing to pay nearly $40 million to resolve claims over false and misleading advertisements for the controversial weedkiller.

In February 2019, several plaintiffs filed a class action lawsuit against Scotts Miracle-Gro Products, Inc. and Monsanto Company, now owned by Bayer, alleging that the manufacturers made false statements that claimed the active ingredient, glyphosate, only targets an enzyme that is not found in humans or pets. The lawsuit was filed in Missouri federal court, alleging that the information was false, because the enzyme is in fact found in both humans and pets.

According to the report by Bloomberg News, Bayer’s Monsanto unit has agreed to pay $39.5 million as part of the Roundup class action settlement. In addition, the company has agreed to remove language from Roundup Weed and Grass Killer labels, which previously indicated glyphosate only affects plant enzymes.


Were you or a loved one exposed to RoundUp?

Exposure to RoundUp has been linked to an increased risk of developing Non-Hodgkin's Lymphoma and other cancers. RoundUp cancer lawsuits are being actively investigated.

Learn More About this Lawsuit See If You Qualify For Compensation

The case is separate from tens of thousands of Roundup lawsuits being pursued against the manufacturer, each involving allegations that exposure to glyphosate caused users to develop non-Hodgkins lymphoma and other injuries.

Bayer officials told Bloomberg News that good faith negotiations continue as part of a process to determine whether other Roundup settlements may be reached to resolve the individual injury claims being pursued in courts nationwide.

Following massive losses in the first three cases to go before juries last year, Bayer has faced substantial pressure to resolve the substantial liability exposure that it now faces from Roundup, and avoid additional trial dates set to begin throughout this year.

More than half a dozen state court cases have already been postponed amid continuing discussions between the parties and the prominent mediator Ken Feinberg, who has overseen many of the largest mass tort settlements in recent years, including the establishment of funds to resolve claims stemming from the BP oil spill, Volkswagen emissions scandal, General Motors ignition switch recall and others.

In early March, the Wall Street Journal reported that Bayer had reached a tentative settlement agreement with several law firms that could resolve thousands of cases. However, no official settlement announcement has been made.

Analysts have predicted that any settlement for the Roundup litigation would not only require billions in compensation for individuals already diagnosed with non-Hodgkins lymphoma, but the company will likely face continuing claims as other consumer continue to be diagnosed following prior exposure.


Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

BioZorb Lawsuit Alleges Breast Tissue Marker Failed, Requiring Surgical Removal
BioZorb Lawsuit Alleges Breast Tissue Marker Failed, Requiring Surgical Removal (Posted 2 days ago)

A BioZorb lawsuit has been filed by several breast cancer survivors after the BioZorb implants moved out of place and failed to dissolve int he body, requiring surgical removal.

Fairness Hearing For Philips CPAP Recall Medical Monitoring Settlement Set for October
Fairness Hearing For Philips CPAP Recall Medical Monitoring Settlement Set for October (Posted 2 days ago)

A U.S. District Court judge has scheduled a fairness hearing for October in order to determine whether final approval should be granted to a $25 million Philips CPAP recall settlement agreement, which would pay former users $25 million to pay for future medical monitoring needs.